Oral Oncology
Volume 37, Issue 6 , Pages 527-536 , September 2001

Characterization of four cell lines derived from a human malignant fibrous histiocytoma of the maxillary sinus

Received 6 November 2000 ,Accepted 13 November 2000.

References 

  1. Ozzelo L, Stout A, Margaret R. Cultural characteristics of malignant fibrous histiocytomas and fibrous xanthomas. Cancer. 1963;16:331–344
  2. Hsu SM, Rohol PJM, Ko YH, Lok MS. Malignant fibrous histiocytoma is not related to histiocytes (consistent phenotypic expression of CD13, CD10, and vimentin in four malignant fibrous histiocytoma cell lines). The Cancer Journal. 1989;3:423–429
  3. Iwasaki H, Isayama T, Ohjima Y, et al.  Malignant fibrous histiocytoma. A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer. 1992;69:437–447
  4. Rohol PJM, Kleyne J, Blokland MV, Spies PL. Characterization of two cell lines, derived from two malignant fibrous histiocytomas. J Pathol. 1986;150:103–112
  5. Roholl PJM, Prinsen I, Radekakers LPHM, Hsu SM, Van Unnik AM. Two cell lines with epitherial cell-like characteristics established from malignant fibrous histiocytomas. Cancer. 1991;68:1963–1972
  6. Takeya M, Yamashiro S, Yoshimura T, Takahashi K. Immunophenotypic and immunoelectron microscopic characterization of major constituent cells in malignant fibrous histiocytoma using human cell lines and their transplanted tumors in immunodeficient mice. Laboratory Investigation. 1995;72:679–687
  7. Takahashi K, Sato K. Establishment and characterization of a human neoplastic cell line(MFH-ino) derived from malignant fibrous histiocytoma of maxilla. Human Cell. 1991;4:51–57
  8. Yonemoto T, Takenouchi T, Tokita H, et al.  Establishment and characterization of a human malignant fibrous histiocytoma cell line. Clinical Orthopaedics and Related Research. 1995;320:159–167
  9. Yokota T, Ishizaki R, Ohishi H, Ohami H. Eatablishment and characterization of fibrous histiocytoma cell line (NMSG 10) derived from a malignant fibrous histiocytoma. Path Res Pract. 1995;191:1231–1238
  10. Fu Y-S, Gabbiani G, Kaye GI, Lattes R. Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas); general considerations and electron microscopic and tissue culture studies. Cancer. 1975;35:176–198
  11. Taxy JB, Battifora H. Malignant fibrous histiocytoma; an electron microscopic study. Cancer. 1977;40:254–267
  12. Brecher ME, Franklin WA. Absence of mononuclear phagocyte antigens in malignant fibrous histiocytoma. Am J Clin Pathol. 1986;86:344–348
  13. Burgdorf WHC, Duray P, Rosai J. Immunohistochemical identification of lysozyme in cutaneous lesion of alleged histiocytic nature. Am J Clin Pathol. 1981;75:162–167
  14. Ding-Feng Li, Iwasaki H, Kikuchi M, Ichiki M, Ogata K. Dermatofibroma: Superficial fibrous prolifaration with reactive histiocytes. A multiple immunostaining analysis. Cancer. 1994;74:66–73
  15. Imai Y, Yamakawa M, Sato T, Suda A. Malignant fibrous histiocytoma (similarities to the “fibrohistiocytoid cells” in chronic inflammation). Virchow Arch A. 1989;414:285–298
  16. Iwasaki H, Isayama T, Johzaki H, Kikuchi M. Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immnocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol. 1987;128:528–537
  17. Iwasaki H, Yoshitake K, Ohjimi Y, et al.  Malignant fibrous histiocytoma. Proliferative compartment and heterogeneity of “histiocytic” cells. Am J Surg Pathol. 1992;16:735–745
  18. Roholl PJM, Kleyne J, Elbers H, Van Der Vegt MCD, Albus-Lutter CH, Van Unnik JAM. Characterization of tumor cells in malignant fibrous histiocytomas and other soft tissue tumors in comparison with malignant histiocytes. Immnohistochemical study on paraffin sections. J Pathol. 1985;147:87–95
  19. Roholl PJM, Kleijne J, Van Unnik JAM. Caracterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes; immunoperoxidase study on cryostat sections. Am J Pathol. 1985;121:269–274
  20. Wood GS, Beckstead JH, Turner RR, Hendrickson MR, Kempson RL, Warnke RA. Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol. 1986;10:323–335
  21. Hirose T, Kudo E, Hasegawa T, Abe J, Hizawa K. Expression of intermediate filaments in malignant fibrous histiocytomas. Human Pathol. 1989;20:871–877
  22. Miettinen M, Soini Y. Malignant fibrous histiocytoma. Heterogeneous patterns of intermediate filament proteins by immunohistochemistry. Arch Pathol Lab Med. 1989;113:1363–1366
  23. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma (fact or fancy? a critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma). Am J Surg Pathol. 1992;16:213–228
  24. Fisher C. Fibrohistiocytic tumors. Monographs in Pathology. 1996;38:162–180
  25. Weiss SW. Histological typing of soft tissue tumours. 2nd ed.. New York, Heidelberg, Berlin: Springer-Verlag; 1994;
  26. Ohse S. Strain establishment and histogenesis of transplantable human malignant fibrous histiocytoma of the maxilla into nude mouse. J Jpn Stomatol Soc. 1989;38:425–437(in Japanese)
  27. Tagawa T, Ohse S, Hamaguchi Y, Hashimoto S, Murata M, Hattori T. A case of malignant fibrous histiocytoma of the right maxilla. Jpn J oral maxillofac surg. 1986;32:441–450(in Japanese)
  28. Okabe T, Suzuki A, Kosaka N, Terashima T. Immune elimination of host fibroblasts for the cultivation of human tumors transplanted into nude mice. Cancer Res. 1979;39:4189–4194
  29. Degerman E, Moos M, Rascon A, et al.  Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase. Biochim Biophys Acta. 1994;1205:189–198
  30. Liesveld JL, Rush S, Kempski MC, et al.  Phenotypic characterization of the human fibrous histiocytoma giant cell tumor(GCT) cell line and its cytokine repertoire. Experimental Hematology. 1993;21:1342–1352
  31. Du Boulay CEH. Demonstration of alph-1-antitrypsin and alph-1-antichymotrypsin in fibrous histiocytomas using the immunoperoxidase technique. Am J Surg Pathol. 1982;6:559–564
  32. Leader M, Patel J, Collins M, Henry K. Anti-α1-antichymotrypsin staining of 194 sarcomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker. Am J Surg Pathol. 1987;11:133–139
  33. Rosenberg AE, O'Connel JX, Dickersin GR, Bhan AK. Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system (An immnohistochemical and electron microscopic study). Human Pathol. 1993;24:284–293
  34. Strauchen JA, Dimitriu-Bona A. Malignant fibrous histiocytoma; expression of monocyte/macrophage differentiation antigens detected with monoclonal antibodies. Am J Pathol. 1986;124:303–309
  35. Kanzaki T, Kitajima S, Suzumori K. Biological behavior of cloned cells of human malignant fibrous histiocytoma in vivo and in vitro. Cancer Res. 1991;51:2133–2137
  36. Shirasuna K, Sugiyama M, Miyazaki T. Establishment and characterization of neoplastic cells from a malignant fibrous histiocytoma. A possible stem cell line. Cancer. 1985;55:2521–2532
  37. Iwasaki H, Kikuchi M, Takii M, Enjoji M. Benign and malignant fibrous histiocytoma of the soft tissues. Functional characterization of the cultured cells. Cancer. 1982;50:520–530
  38. Genberg M, Mark J, Hakelius L, Ericsson J, Nister M. Origin and relationship between different cell types in malignant fibrous histiocytoma. Am J Pathol. 1989;135:1185–1196
  39. Meister P, Hohne N, Konrad E, Edor M. Fibrous histiocytoma (an analysis of the storiform pattern). Virchow Arch A. 1979;383:31–41
  40. Rohol PJM, Rademakers LHPM, Weger RA, De Elbers JRJ, Unnik JAMV. Characterization of human soft tissue sarcoma in nude mice. Evidence for histogenic properties of malignant fibrous histiocytomas. Am J Pathol. 1988;131:559–568
  41. Katenkamp D, Neupert G. Experimental tumors with features of malignant fibrous histiocytomas. Exp Path. 1982;22:11–27
  42. Davies KA, Cope AP, Schofield JB, et al.  A and rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol. 1995;99:117–123
  43. Melhem MF, Meisler AI, Saito R, Finley GG, Hockman HR, Kosky RA. Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction. Blood. 1993;82:2038–2044
  44. Serke S, Brenner M, Zimmermenn R, Lobeck H. Malignant fibrous histiocytoma associated with peripheral blood eosinophilia. In vitro studies demonstrating tumor-derived eosinophilopoietic activity. Oncology. 1986;43:230–233
  45. Takahashi K, Kimura Y, Naito M, Yoshimura T, Uchida H, Araki S. Inflammatory fibrous histioctoma presenting leukemoid reaction. Path Res Pract. 1989;184:498–506
  46. Yoshida M, Matsuzaki H, Hata H, et al.  Neutrophil chemotactic factors produced by malignant fibrous histiocytoma cell lines. Br J Cancer. 1993;67:508–513
  47. Manganiello VC, Murata T, Taira M, et al.  Perspectives in biochemistry and biophysics. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch. Biochem. Biophys. 1995;322:1–13
  48. Degerman E, Belfrage P, Manganiello VC. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem. 1997;272:6823–6826
  49. Dress M, Zimmernann R, Eisenbrand G. 3′,5′-cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res. 1993;53:3058–3061

PII: S1368-8375(01)00004-5

Oral Oncology
Volume 37, Issue 6 , Pages 527-536 , September 2001

Article Tools

* Image Usage & Resolution